NORTHWEST BIOTHERAPEUTICS INC Quarterly Interest Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Northwest Biotherapeutics Inc quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2024.
  • Northwest Biotherapeutics Inc Interest Expense for the quarter ending March 31, 2024 was $1.52M, a 47.8% increase year-over-year.
  • Northwest Biotherapeutics Inc Interest Expense for the twelve months ending March 31, 2024 was $5.73M, a 10.4% increase year-over-year.
  • Northwest Biotherapeutics Inc annual Interest Expense for 2023 was $5.24M, a 13.6% decline from 2022.
  • Northwest Biotherapeutics Inc annual Interest Expense for 2022 was $6.07M, a 21.1% increase from 2021.
  • Northwest Biotherapeutics Inc annual Interest Expense for 2021 was $5.01M, a 41.4% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.73M $1.52M +$491K +47.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $5.24M $1.24M +$21K +1.72% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $5.22M $1.67M +$158K +10.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $5.06M $1.3M -$130K -9.08% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $5.19M $1.03M -$876K -46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $6.07M $1.22M +$68K +5.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $6M $1.51M -$92K -5.74% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $6.09M $1.43M +$625K +77.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $5.47M $1.9M +$456K +31.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $5.01M $1.15M -$167K -12.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $5.18M $1.6M -$3.94M -71% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $9.11M $807K -$252K -23.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $9.37M $1.45M +$822K +132% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $8.54M $1.32M +$612K +86.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $7.93M $5.54M +$4.82M +665% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $3.12M $1.06M +$272K +34.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $2.84M $625K -$131K -17.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $2.98M $708K -$941K -57.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $3.92M $724K -$872K -54.6% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-15
Q2 2019 $4.79M $787K -$2.52M -76.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $7.3M $756K -$2.57M -77.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-24
Q4 2018 $9.87M $1.65M -$201K -10.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $10.1M $1.6M +$403K +33.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $9.67M $3.3M +$1.99M +152% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $7.68M $3.32M +$2.13M +178% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $5.55M $1.85M +$170K +10.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-02
Q3 2017 $5.38M $1.19M +$502K +72.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 $4.87M $1.31M +$579K +79.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $4.29M $1.19M +$476K +66.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-16
Q4 2016 $3.82M $1.68M +$1M +148% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 $2.82M $691K -$355K -33.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 $3.17M $729K -$907K -55.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 $4.08M $718K -$75K -9.46% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $4.15M $678K +$108K +18.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 $4.05M $1.05M +$775K +286% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $3.27M $1.64M +$1.6M +4858% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $1.67M $793K +$671K +550% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 $996K $570K +$434K +319% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-16
Q3 2014 $562K $271K +$205K +311% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $357K $33K -$157K -82.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $514K $122K -$328K -72.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $842K $136K -$3.68M -96.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-16
Q3 2013 $4.52M $66K -$2.72M -97.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 $7.24M $190K -$1.42M -88.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-15
Q1 2013 $8.67M $450K -$4.78M -91.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $13.4M $3.82M +$1.59M +71.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-01
Q3 2012 $11.8M $2.79M +$418K +17.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 $11.4M $1.61M +$48K +3.07% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $11.4M $5.23M +$3.73M +250% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $7.65M $2.22M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-08
Q3 2011 $2.37M -$1K -0.04% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $1.57M +$466K +42.4% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-12
Q1 2011 $1.49M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 $2.37M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $1.1M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.